Moreover, in CRC patients with high Jagged1 expression, the lower expression of MFNG is significantly associated with poor CRC prognosis, suggesting that the Jagged1-high/MFNG-low pattern highlights a CRC subset that could benefit from Jagged1 inhibition. The gene discussed is MFNG; the disease is colorectal carcinoma.